John Byrd has received the Binet-Rai Medal Award for his research findings, which led to the use of Bruton tyrosine kinase inhibitors in almost every phase of chronic lymphocytic leukemia therapy.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe